Dec 23 (Reuters) - Providence Therapeutics:
* PROVIDENCE THERAPEUTICS -CO'S COVID-19 VACCINE RECEIVES HEALTH CANADA AUTHORIZATION, TO BEGIN CLINICAL TRIALS
* PROVIDENCE THERAPEUTICS -HEALTH CANADA'S AUTHORIZATION MEANS PHASE I CLINICAL TRIALS WILL BEGIN EARLY IN 2021
* PROVIDENCE THERAPEUTICS - LATER PHASE CLINICAL TRIALS FOR ITS COVID-19 VACCINE ARE EXPECTED TO PROCEED IN 2021, SUBJECT TO REGULATORY APPROVAL